Retension Pharmaceuticals, Inc. (RTSN)

NASDAQ: RTSN · Real-Time Price · USD

15.50

+0.50 (3.33%)

At close: Oct 22, 2026, 4:00 PM EDT

16.38

+0.88 (5.68%)

After-hours: Oct 22, 2026, 7:50 PM EDT

Retension Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Income	-14.86	-6.88	-2.28	-0.27
Net Income	-14.24	-6.3	-1.91	-0.21
Earnings Per Share	-17.67	-7.83	-2.37	-0.26
EPS Growth	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Cash (Debt)	13.49	18.9	8.19	6.33
Net Cash Growth	113.31%	130.91%	29.40%	-
Net Cash Per Share	16.74	23.48	10.17	7.86
Cash & Investments	13.49	18.9	8.19	6.33

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-11.89	-7.78	-1.76	-0.08
Free Cash Flow	-11.89	-7.78	-1.76	-0.08
Free Cash Flow Growth	-	-	-	-